HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tanja Gmeiner-Stopar Selected Research

Neoplasms (Cancer)

4/2011Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tanja Gmeiner-Stopar Research Topics

Disease

1Infant Death
08/2011
1Chorioamnionitis
08/2011
1Inflammation (Inflammations)
08/2011
1Rupture
08/2011
1fetal inflammatory response syndrome
08/2011
1Neoplasms (Cancer)
04/2011
1medullary Thyroid cancer
04/2011
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2011
1Sepsis (Septicemia)
11/2009
1Critical Illness (Critically Ill)
11/2009

Drug/Important Bio-Agent (IBA)

1Interleukin-6 (Interleukin 6)IBA
08/2011
1DefensinsIBA
08/2011
1Glutamic Acid (Glutamate)FDA Link
04/2011
1Cholecystokinin B ReceptorIBA
04/2011
1GastrinsIBA
04/2011
1C-Reactive ProteinIBA
11/2009
1ProcalcitoninIBA
11/2009
1lipopolysaccharide-binding proteinIBA
11/2009